BEIGENE(ONC) - 2025 Q4 - Annual Results
BEIGENEBEIGENE(US:ONC)2026-02-26 11:04

Exhibit 99.1 BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership SAN CARLOS, Calif. – February 26, 2026 – BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the fourth quarter and full year 2025. "These strong financial results for the fourth quarter and full year 2025 underscore our continued evolution as a ...